Terms: = Gastric cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Diagnosis
8 results:
1. Primary Ntrk -rearranged Spindle Cell Neoplasm of the Gastrointestinal Tract: A Clinicopathological and Molecular Analysis of 8 Cases.
Gao X; Xu S; Zhu P; Lao IW; Yu L; Wang J
Am J Surg Pathol; 2024 May; 48(5):623-631. PubMed ID: 38525823
[TBL] [Abstract] [Full Text] [Related]
2. Further prognostic stratification of intestinal type of gastric adenocarcinoma by CDX2 expression pattern.
Hao Y; Liu BL; Liang Y; Xiong Y; Polydorides AD; Ward S
Hum Pathol; 2023 Jan; 131():61-67. PubMed ID: 36403867
[TBL] [Abstract] [Full Text] [Related]
3. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
Regazzo D; Bertazza L; Galletta E; Barollo S; Mondin A; Zovato S; Iacobone M; Zilio E; Scaroni C; Radu CM; di Benedetto G; Mian C; Lefkimmiatis K; Occhi G
Endocr Relat Cancer; 2022 Apr; 29(5):273-284. PubMed ID: 35298396
[TBL] [Abstract] [Full Text] [Related]
4. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract] [Full Text] [Related]
5. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract] [Full Text] [Related]
6. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Behr TM; Béhé MP
Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
[TBL] [Abstract] [Full Text] [Related]
7. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract] [Full Text] [Related]
8. Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin.
Behr TM; Jenner N; Radetzky S; Béhe M; Gratz S; Yücekent S; Raue F; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):424-30. PubMed ID: 9553173
[TBL] [Abstract] [Full Text] [Related]